Biotech China 2014

Mesoblast gets US patent for bone repair products

Australia's regenerative medicine company, Mesoblast said that the US Patent and Trademark Office has granted a key patent that provides exclusive commercial protection for its bone tissue generating products through to at least the year 2019 in the US, the world's largest market for regenerative medicines.

http://www.biospectrumasia.com/content/030310AUS12165.asp



Comments

POSTED:2012-07-29 09:15:31

AUTHOR: GUEST

bohU2G , [url=http://ssohoyrdwttx.com/]ssohoyrdwttx[/url], [link=http://edfaucruntfu.com/]edfaucruntfu[/link], http://bvirhcollomg.com/


POSTED:2012-07-27 05:19:27

AUTHOR: GUEST

VCgLp5 <a href="http://qlhoolhrnhgg.com/">qlhoolhrnhgg</a>


POSTED:2012-07-26 19:12:48

AUTHOR: GUEST

A fair point. Not all plaintiffs in pneatt lawsuits are well-financed, sophisticated companies. Sometimes the plaintiffs are small companies or inventors that are simply trying to protect what's theirs. To those plaintiffs I say "Good luck--and go get 'em." In fact, I represent many plaintiffs who are in that exact position.But unfortuntely, there is also a proliferation of pneatt trolls, especially in the tech and telecom industries, that own dubious (at best) pneatts, and who threaten innovation for the sake of making a few dollars.Thanks for your comments.Brad


4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.